Work

6603 A phase II study of erlotinib in patients (pts) with advanced pancreatic cancer (APC) who are refractory to gemcitabine (G)

Year: 2009

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(09)71324-2

Authors: R. Iyer, N. Khushalani, W. Tan, A. Litwin, C. LeVea, A. Hutson, C. Tucker, W. Ma, M. Fakih, A. Adjei

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1991119277

Cites:

Cited by: 5

Related to: 10